SCHEMBL25002892

SCHEMBL25002892

CCCCOc1ccc(-c2nccc(C(=O)OC)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.52
▸ RAB9A P51151 4/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ ALPL P05186 1/20 0.51
▸ LMNA P02545 4/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ PLA2G2A P14555 2/20 0.49
▸ TSHR P16473 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MAPT P10636 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002912 0.95 PLA2G2A (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL25002930 0.89 RAB9A (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL25003134 0.86 NPC1 (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL25002922 0.85 KMT2A (0.56) NPC1SMN1; SMN2ALDH1A1KDM4EL3MBTL1
SCHEMBL20746299 0.82 KMT2A (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL7338798 0.82 MAPT (0.55) NPC1SMN1; SMN2ALDH1A1KDM4EALPL
SCHEMBL25003794 0.81 PLK1 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL25002900 0.80 KMT2A (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL25002901 0.80 ADORA3 (0.49) NPC1RAB9ASMN1; SMN2L3MBTL1MAPT
SCHEMBL25002890 0.79 MAP4K4 (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback